[PHARMA] YoY Quarter Result on 30-Jun-2017 [#2]

Announcement Date
16-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- -49.69%
YoY- -36.51%
Quarter Report
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 645,763 601,890 582,729 517,967 531,796 512,845 525,072 3.50%
PBT 14,326 12,481 11,970 10,150 21,487 25,056 24,622 -8.62%
Tax -4,719 -3,219 -6,204 -399 -5,846 -8,414 -8,665 -9.62%
NP 9,607 9,262 5,766 9,751 15,641 16,642 15,957 -8.10%
-
NP to SH 9,979 9,281 5,394 9,520 14,995 16,217 15,975 -7.53%
-
Tax Rate 32.94% 25.79% 51.83% 3.93% 27.21% 33.58% 35.19% -
Total Cost 636,156 592,628 576,963 508,216 516,155 496,203 509,115 3.77%
-
Net Worth 357,891 518,564 519,642 542,147 524,177 528,477 502,293 -5.48%
Dividend
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Div 6,530 6,514 10,392 10,376 12,949 18,134 10,356 -7.39%
Div Payout % 65.45% 70.19% 192.67% 108.99% 86.36% 111.82% 64.83% -
Equity
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Net Worth 357,891 518,564 519,642 542,147 524,177 528,477 502,293 -5.48%
NOSH 261,705 261,229 259,821 259,400 258,981 259,057 258,914 0.17%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 1.49% 1.54% 0.99% 1.88% 2.94% 3.25% 3.04% -
ROE 2.79% 1.79% 1.04% 1.76% 2.86% 3.07% 3.18% -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 247.20 230.98 224.28 199.68 205.34 197.97 202.80 3.35%
EPS 3.82 3.56 2.08 3.67 5.79 6.26 6.17 -7.67%
DPS 2.50 2.50 4.00 4.00 5.00 7.00 4.00 -7.52%
NAPS 1.37 1.99 2.00 2.09 2.024 2.04 1.94 -5.62%
Adjusted Per Share Value based on latest NOSH - 259,400
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 44.81 41.76 40.43 35.94 36.90 35.58 36.43 3.50%
EPS 0.69 0.64 0.37 0.66 1.04 1.13 1.11 -7.61%
DPS 0.45 0.45 0.72 0.72 0.90 1.26 0.72 -7.52%
NAPS 0.2483 0.3598 0.3606 0.3762 0.3637 0.3667 0.3485 -5.48%
Price Multiplier on Financial Quarter End Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 -
Price 2.22 2.84 2.88 4.58 5.50 7.13 4.61 -
P/RPS 0.90 1.23 1.28 2.29 2.68 3.60 2.27 -14.27%
P/EPS 58.12 79.74 138.73 124.80 94.99 113.90 74.72 -4.09%
EY 1.72 1.25 0.72 0.80 1.05 0.88 1.34 4.24%
DY 1.13 0.88 1.39 0.87 0.91 0.98 0.87 4.45%
P/NAPS 1.62 1.43 1.44 2.19 2.72 3.50 2.38 -6.20%
Price Multiplier on Announcement Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 19/08/20 23/08/19 17/08/18 16/08/17 19/08/16 17/08/15 21/08/14 -
Price 4.42 2.66 3.11 4.19 5.62 5.65 4.62 -
P/RPS 1.79 1.15 1.39 2.10 2.74 2.85 2.28 -3.94%
P/EPS 115.71 74.69 149.80 114.17 97.06 90.26 74.88 7.51%
EY 0.86 1.34 0.67 0.88 1.03 1.11 1.34 -7.11%
DY 0.57 0.94 1.29 0.95 0.89 1.24 0.87 -6.79%
P/NAPS 3.23 1.34 1.56 2.00 2.78 2.77 2.38 5.21%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment